Immunity against poliomyelitis in the Netherlands, assessed in 2006 to 2007: the importance of completing a vaccination seriesN.A.T. van der Maas, L. Mollema, G.A.M. Berbers, D.M. van Rooijen, H.G. van der Avoort, M.A.E. van Spaendonck, H.E. de Melker, F.R. van der KlisJournal Article
Randomized trial to assess the immunogenicity, safety and antibody persistence up to three years after a single dose of a tetravalent meningococcal serogroups A, C, W-135 and Y tetanus toxoid conjugate vaccine in toddlersT. Vesikari, A. Forsten, D. Boutriau, V. Bianco, M. van der Wielen, J.M. MillerJournal Article
Impact of an adolescent meningococcal ACWY immunisation programme to control a national outbreak of group W meningococcal disease in England: a national surveillance and modelling studyH. Campbell, N. Andrews, S.R. Parikh, J. White, M. Edelstein, X. Bai, et al.Journal Article
Vaccine Impact and Effectiveness of Meningococcal Serogroup ACWY Conjugate Vaccine Implementation in the Netherlands: A Nationwide Surveillance StudyM. Ohm, S.J.M. Hahne, A. van der Ende, E.A.M. Sanders, G.A.M. Berbers, W.L. Ruijs, N.M. van Sorge, H.E. de Melker, M.J. KnolJournal Article
Epidemic of mumps among vaccinated persons, the Netherlands, 2009-2012J. Sane, S. Gouma, M. Koopmans, H. de Melker, C. Swaan, R. van Binnendijk, S. HahneJournal Article